scholarly article | Q13442814 |
P356 | DOI | 10.1158/1055-9965.EPI-04-0866 |
P8608 | Fatcat ID | release_lzclyukspvc75ojp2yjgk3gc6u |
P698 | PubMed publication ID | 16835340 |
P50 | author | Steven Gallinger | Q28360456 |
P2093 | author name string | Jean Jenkins | |
Ilan R Kirsch | |||
Gary Gordon | |||
Patrick Lynch | |||
Henry Lynch | |||
Ernest Hawk | |||
Peter Soballe | |||
Sherri Patterson | |||
Luz M Rodriguez | |||
Janet Cliatt | |||
Kenneth Nakahara | |||
Oleg K Glebov | |||
Aby Buchbinder | |||
John Denobile | |||
Casey-Jo Humbyrd | |||
P2860 | cites work | Mistaken identifiers: gene name errors can be introduced inadvertently when using Excel in bioinformatics | Q24803868 |
P433 | issue | 7 | |
P304 | page(s) | 1382-1391 | |
P577 | publication date | 2006-07-01 | |
P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
P1476 | title | Celecoxib treatment alters the gene expression profile of normal colonic mucosa | |
P478 | volume | 15 |
Q28647460 | A reproducible approach to high-throughput biological data acquisition and integration |
Q33862407 | Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. |
Q33639871 | Assessing efficacy in early-phase cancer prevention clinical trials: the case of ki-67 in the lung |
Q36935231 | Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation |
Q35445907 | Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women |
Q91672650 | Drug-induced gene expression profile changes in relation to intestinal toxicity: State-of-the-art and new approaches |
Q39906264 | Persistent cyclooxygenase-2 inhibition downregulates NF-{kappa}B, resulting in chronic intestinal inflammation in the min/+ mouse model of colon tumorigenesis |
Q37719555 | Pharmacotherapy for inherited colorectal cancer |
Q34112511 | Phase II cancer prevention clinical trials |
Search more.